Company Snapshot
- Ticker
- LH
- Name
- LH
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 21953358000.000000
- Volume
- 414,838
- Avg Volume (3M)
- 682,586
LH
LH
Last update recent
264.18
-0.55
(-0.21%)
Market Cap
21953358000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 13765300000.000000
- EPS
- 10.26
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 1.1%
- Net Income
- 855200000.000000
- Net Margin
- 6.21%
- Payout Ratio
- 28.24%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 25.67
- Forward P/E
- None
- P/S
- 1.59
- P/B
- 2.52
- Beta
- None
- Debt / Equity
- 0.75
- Current Ratio
- 1.55
- Return on Equity
- 0.10%
- Return on Assets
- 0.05%
Technicals & Returns
- Distance vs 200 DMA
- 3.11%
- 200 DMA
- 256.21
- Distance vs 50 DMA
- -1.11%
- 50 DMA
- 267.14
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and a Read more
- Name
- LH
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Adam H. Schechter
- Employees
- 67,000
- IPO Date
- 1990-03-29
- Phone
- 336 229 1127
- Address
- None
- Website
- https://www.labcorp.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-08-29 • $0.72
Latest News
Curated headlines from premium sources.
Is the Options Market Predicting a Spike in Labcorp Holdings Stock?
Investors need to pay close attention to LH stock based on the movements in the options market lately.
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today…
Cerity Partners LLC Has $21.64 Million Stock Holdings in Labcorp Holdings Inc. $LH
Cerity Partners LLC decreased its position in Labcorp Holdings Inc. (NYSE: LH) by 2.8% in the undefined quarter, according to the company in its most recent fi…
Ariel Investments LLC Sells 2,865 Shares of Labcorp Holdings Inc. $LH
Ariel Investments LLC lessened its position in Labcorp Holdings Inc. (NYSE: LH) by 0.8% in the second quarter, according to the company in its most recent fili…
Rep. April McClain Delaney Buys Brown & Brown, Inc. (NYSE:BRO) Stock
Representative April McClain Delaney (D-Maryland) recently bought shares of Brown and Brown, Inc. (NYSE: BRO). In a filing disclosed on December 08th, the Repr…
Rep. April McClain Delaney Purchases Shares of Labcorp Holdings Inc. (NYSE:LH)
Representative April McClain Delaney (D-Maryland) recently bought shares of Labcorp Holdings Inc. (NYSE: LH). In a filing disclosed on December 08th, the Repre…